REQUEST A DEMO
Total
USD $0.00
Search more companies

Dci Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Dci Pharmaceuticals Private Limited Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Dci Pharmaceuticals Private Limited is an unlisted company, incorporated on 29/12/1975. It has its registered office in the State of Goa, India. Company's corporate identification number (CIN) is U24231GA1975PTC000251 and registration number is 000251. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
Anand Bhavan Old Station Road
South Goa; Goa; Postal Code: 403601

Contact Details: Purchase the Dci Pharmaceuticals Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Dci Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Dci Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
December 29, 1975
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Whole Time Director
Ownership Details
Purchase this report to view the information.
40%
Purchase this report to view the information.
30%
Purchase this report to view the information.
30%
Company Performance
Financial values in the chart are available after Dci Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
2.98%
Total operating revenue
2.94%
Operating profit (EBIT)
-7.89%
EBITDA
0.78%
Net Profit (Loss) for the Period
N/A
Total assets
31.36%
Total equity
2.78%
Operating Profit Margin (ROS)
-0.74%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-98.75%
Quick Ratio
0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?